跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
潘 宏基
臺北神經醫學中心
https://orcid.org/0000-0001-7560-4456
h-index
411
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1990 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(36)
類似的個人檔案
(6)
指紋
查看啟用 Hung-Chi Pan 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Gamma Knife Radiosurgery
100%
Neoplasm
74%
Stereotactic Radiosurgery
64%
Radiosurgery
42%
Brain Metastasis
40%
Cavernous Hemangioma
30%
Radiation Therapy
25%
Epidermal Growth Factor Receptor
23%
Craniopharyngioma
20%
Neuroepithelioma
20%
Vestibular Schwannoma
20%
Dural Arteriovenous Fistula
20%
Meta-Analysis
20%
Overall Survival
18%
Magnetic Resonance Imaging
14%
Metastatic Carcinoma
14%
Tumor Progression
12%
Tyrosine-Kinase Inhibitor
11%
Progression Free Survival
11%
Bleeding
10%
Intracranial Tumor
10%
Surgery
10%
Body Mass Index
10%
Lung Cancer
10%
Vision
10%
Pediatrics
10%
Cerebral Arteriovenous Malformation
10%
Oligoastrocytoma
10%
Treatment of Non-Small Cell Lung Cancer
10%
Mature Teratoma
10%
Glossopharyngeal Neuralgia
10%
Macroadenoma
10%
Systematic Review
10%
Squamous Cell
10%
Lung
10%
Non-Small Cell Lung Cancer
10%
Retrospective Cohort Study
10%
Arm
10%
Survival Rate
9%
Radiation Response
8%
Adjuvant Therapy
7%
Cavernous Sinus
6%
Recurrent Disease
6%
Proportional Hazards Model
5%
Pediatrics Patient
5%
Phosphorus
5%
Phosphorus 32
5%
Major Surgery
5%
Yttrium 90
5%
Conventional Angiography
5%
Neuroscience
Arteriovenous Malformation
40%
Epidermal Growth Factor Receptor
33%
Radiation Therapy
30%
Parenchyma
26%
Magnetic Resonance Imaging
26%
Tyrosine Kinase Inhibitor
21%
Cavernous Sinus
21%
Magnetic Resonance Imaging
16%
Peripheral Neuropathy
13%
Brain Cancer
11%
Astrocytoma
10%
Body Mass Index
10%
Meningioma
10%
Acromegaly
10%
Occipital Neuralgia
10%
Craniopharyngioma
10%
Machine Learning Algorithm
10%
Ependymoma
10%
Optic Nerve
10%
Visual Field Defect
10%
Meta-Analysis
10%
Intracranial Tumor
10%
Leukoencephalopathy
10%
Adverse Effect
10%
Immunotherapy
10%
Radiation Therapy
10%
Endocrine Disease
5%
Computed Tomography
5%
Hypopituitarism
5%
Hypertension
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
60%
Brain Metastasis
50%
Epidermal Growth Factor Receptor
33%
Overall Survival
22%
Protein Tyrosine Kinase Inhibitor
21%
Non Small Cell Lung Cancer
20%
Neuroepithelioma
20%
Intracranial Tumor
12%
Cohort Study
12%
Metastasis
10%
Acromegaly
10%
Lung Cancer
10%
Remission
10%
Ependymoma
10%
Cavernous Hemangioma
10%
Meningioma
10%
Bleeding
8%
Progression Free Survival
7%
Survival Rate
7%
Squamous Cell Lung Carcinoma
6%
Immunotherapy
6%
Hormone Deficiency
5%
